122 related articles for article (PubMed ID: 35758823)
1. Prophylactic Antitubercular Therapy Is Associated With Accelerated Disease Progression in Patients With Crohn's Disease Receiving Anti-TNF Therapy: A Retrospective Multicenter Study.
Liu F; Tang J; Ye L; Tan J; Qiu Y; Hu F; He J; Chen B; He Y; Zeng Z; Mao R; Cao Q; Gao X; Chen M
Clin Transl Gastroenterol; 2022 Jun; 13(6):e00493. PubMed ID: 35758823
[TBL] [Abstract][Full Text] [Related]
2. Antitubercular Therapy Given to Differentiate Crohn's Disease From Intestinal Tuberculosis Predisposes to Stricture Formation.
Gupta A; Pratap Mouli V; Mohta S; Kante B; Kalaivani M; Madhu D; Sahu P; Kumar S; Sharma R; Sahni P; Das P; Gupta SD; Makharia G; Kedia S; Ahuja V
J Crohns Colitis; 2020 Nov; 14(11):1611-1618. PubMed ID: 32369567
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
4. Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
Cernoch PS; Fournier N; Zeitz J; Scharl M; Morell B; Greuter T; Schreiner P; Misselwitz B; Safroneeva E; Schoepfer AM; Vavricka SR; Rogler G; Biedermann L;
Dig Dis Sci; 2020 Sep; 65(9):2654-2663. PubMed ID: 31797187
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral Centers.
Rivière P; Kanters C; Pellet G; Ni A; Hupé M; Aboulhamid N; Poullenot F; Bitton A; Zerbib F; Lakatos PL; Afif W; Laharie D; Bessissow T
Inflamm Bowel Dis; 2023 Jun; 29(6):923-931. PubMed ID: 35917111
[TBL] [Abstract][Full Text] [Related]
6. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
[TBL] [Abstract][Full Text] [Related]
7. Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy.
Ten Bokkel Huinink S; Beelen EMJ; Ten Bokkel Huinink T; Hoentjen F; G L Bodelier A; Dijkstra G; Romberg-Camps M; de Boer NK; Stassen LPS; van der Meulen AE; West R; van Ruler O; van der Woude CJ; de Vries AC;
Eur J Gastroenterol Hepatol; 2023 Jan; 35(1):45-51. PubMed ID: 36468568
[TBL] [Abstract][Full Text] [Related]
8. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis.
Cañete F; Mañosa M; Pérez-Martínez I; Barreiro-de Acosta M; González-Sueyro RC; Nos P; Iglesias-Flores E; Gutiérrez A; Bujanda L; Gordillo J; Ríos León R; Casanova MJ; Villoria A; Rodríguez-Lago I; López Serrano P; García-Herola A; Ramírez-de la Piscina P; Navarro-Llavat M; Taxonera C; Barrio J; Ramos L; Navarro P; Benítez-Leiva O; Calafat M; Domènech E;
Clin Transl Gastroenterol; 2020 Aug; 11(8):e00218. PubMed ID: 32955190
[TBL] [Abstract][Full Text] [Related]
9. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
Rodríguez-Lago I; Hoyo JD; Pérez-Girbés A; Garrido-Marín A; Casanova MJ; Chaparro M; Fernández-Clotet A; Castro-Poceiro J; García MJ; Sánchez S; Ferreiro-Iglesias R; Bastón I; Piqueras M; Careda LEIB; Mena R; Suárez C; Cordón JP; López-García A; Márquez L; Arroyo M; Alfambra E; Sierra M; Cano N; Delgado-Guillena P; Morales-Alvarado V; Aparicio JC; Guerra I; Aulló C; Merino O; Arranz L; Hidalgo MA; Llaó J; Plaza R; Molina G; Torres P; Pérez-Galindo P; Romero MG; Herrera-deGuise C; Armesto E; Mesonero F; Frago-Larramona S; Benítez JM; Calvo M; Martín MDCL; Elorza A; Larena A; Peña E; Rodríguez-Grau MDC; Miguel-Criado J; Botella B; Olmos JA; López L; Aguirre U; Gisbert JP;
United European Gastroenterol J; 2020 Nov; 8(9):1056-1066. PubMed ID: 32723069
[TBL] [Abstract][Full Text] [Related]
10. Impact of medical therapy on patients with Crohn's disease requiring surgical resection.
Fu YT; Hong T; Round A; Bressler B
World J Gastroenterol; 2014 Sep; 20(33):11808-14. PubMed ID: 25206286
[TBL] [Abstract][Full Text] [Related]
11. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
Oh EH; Oh K; Han M; Seo H; Chang K; Lee SH; Kim GU; Song EM; Seo M; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
PLoS One; 2017; 12(5):e0177479. PubMed ID: 28542298
[TBL] [Abstract][Full Text] [Related]
12. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
[TBL] [Abstract][Full Text] [Related]
13. Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study.
Ye BD; Hong SN; Seo SI; Kim YJ; Cha JM; Rhee KH; Yoon H; Kim YH; Kim KH; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Park SH; Yang SK;
Gut Liver; 2022 Mar; 16(2):216-227. PubMed ID: 34148870
[TBL] [Abstract][Full Text] [Related]
14. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA; Heap GA; Green HD; Hamilton B; Bewshea C; Walker GJ; Thomas A; Nice R; Perry MH; Bouri S; Chanchlani N; Heerasing NM; Hendy P; Lin S; Gaya DR; Cummings JRF; Selinger CP; Lees CW; Hart AL; Parkes M; Sebastian S; Mansfield JC; Irving PM; Lindsay J; Russell RK; McDonald TJ; McGovern D; Goodhand JR; Ahmad T;
Lancet Gastroenterol Hepatol; 2019 May; 4(5):341-353. PubMed ID: 30824404
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysis.
Narula N; Wong ECL; AlRamdan R; Bualbanat H; Marshall JK; Steinhart AH; Greener T; Silverberg MS
J Gastroenterol Hepatol; 2021 Oct; 36(10):2803-2812. PubMed ID: 34020510
[TBL] [Abstract][Full Text] [Related]
16. Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn's Disease: A Comparative Cohort Study.
Chan M; Fung M; Chin Koon Siw K; Khanna R; de Buck van Overstraeten A; Sabri E; McCurdy JD
Inflamm Bowel Dis; 2023 May; 29(5):763-770. PubMed ID: 35815783
[TBL] [Abstract][Full Text] [Related]
17. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn's disease.
Vuyyuru SK; Kante B; Kumar P; Sahu P; Kedia S; Ranjan MK; Sharma R; Panwar R; Makharia G; Ahuja V
Sci Rep; 2021 Jun; 11(1):11704. PubMed ID: 34083575
[TBL] [Abstract][Full Text] [Related]
18. Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization.
Geem D; Hercules D; Pelia RS; Venkateswaran S; Griffiths A; Noe JD; Dotson JL; Snapper S; Rabizadeh S; Rosh JR; Baldassano RN; Markowitz JF; Walters TD; Ananthakrishnan A; Sharma G; Denson LA; Hyams JS; Kugathasan S
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):368-376.e4. PubMed ID: 37802268
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for rebleeding in Crohn's disease patients with acute severe lower gastrointestinal bleeding: With special reference to the role of anti-tumor necrosis factor therapy.
Kim DS; Yoon J; Kim YJ; Lee JW; Hong SW; Hwang HW; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
J Gastroenterol Hepatol; 2021 Sep; 36(9):2455-2462. PubMed ID: 33734479
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic features of Crohn's disease associated with failure of medical treatment.
Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
